Detection of carbapenemase- and ESBL-producing Klebsiella pneumoniae from bovine bulk milk and comparison with clinical human isolates in Italy

被引:7
|
作者
Bonardi, S. [1 ]
Cabassi, C. S. [1 ]
Fiaccadori, E. [2 ]
Cavirani, S. [1 ]
Parisi, A. [3 ]
Bacci, C. [1 ]
Lamperti, L. [1 ]
Rega, M. [1 ]
Conter, M. [1 ]
Marra, F. [1 ]
Crippa, C. [4 ]
Gambi, L. [4 ]
Spadini, C. [1 ]
Iannarelli, M. [1 ]
Paladini, C. [5 ]
Filippin, N. [5 ]
Pasquali, F. [4 ]
机构
[1] Univ Parma, Dept Vet Sci, Str Taglio 10, I-43126 Parma, Italy
[2] Parma Univ, Parma Univ Hosp, Dept Med & Surg, Nephrol Unit, Via Gramsci 24, I-43126 Parma, Italy
[3] Ist Zooprofilatt Sperimentale Puglia & Basilicata, Via Chiancolla 1, I-70017 Putignano, BA, Italy
[4] Univ Bologna, Dept Agr & Food Sci Alma Mater Studiorum, Food Safety Unit, Via Florio 2, I-40064 Ozzano DellEmilia, BO, Italy
[5] Natl Vet Serv, Via Vasari 13-A, I-43126 Parma, Italy
关键词
KPC-3 Klebsiella pneumoniae; Sequence type 307; Dairy cattle; One Health; WASTE-WATER; ANTIBIOTIC-RESISTANCE; ENTEROBACTERIACEAE; OUTBREAK; MASTITIS; SUSCEPTIBILITY; DISSEMINATION; ENVIRONMENT; GENES; ROUTE;
D O I
10.1016/j.ijfoodmicro.2022.110049
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Klebsiella pneumoniae is the most common Klebsiella species infecting animals and is one of the causing agents of mastitis in cows. The rise of antimicrobial resistance in K. pneumoniae, particularly in strains producing extendedspectrum beta-lactamases (ESBLs) and/or carbapenemases, is of concern worldwide. Recently (Regulation UE No 2022/1255), carbapenems and cephalosporins in combination with beta-lactamase inhibitors have been reserved only to human treatments in the European Union. The aim of this study was to investigate the role of cattle as carrier of human pathogenic carbapenem-resistant (CR) and ESBL-producing K. pneumoniae. On this purpose, a study involving 150 dairy farms in Parma province (Northern Italy) and 14 non replicate K. pneumoniae isolates from patients admitted at Parma University-Hospital was planned. Four multidrug resistant (MDR) K. pneumoniae strains were detected from 258 milk filters collected between 2019 and 2021. One carbapenemase KPC-3-positive K. pneumoniae ST307 (0.4 %; 95 % CI - 0.07 - 2.2) was detected in milk filters. The isolate also harboured OXA-9, CTX-M-15 and SHV-106 determinants, together with genes conferring resistance to aminoglycosides (aac(3')-IIa, aph (3'')-Ib, aph (6)-Id), fluoroquinolones (oqxA, oqxB, qnrB1), phosphonic acids (fosA6), sulphonamides (sul2), tetracyclines (tet(A)6) and trimethoprim (dfrA14). One KPC-3-producing K. pneumoniae ST307 was identified also among the human isolates, thus suggesting a possible circulation of pathogens out of the clinical settings. The remaining three bovine isolates were MDR ESBL-producing K. pneumoniae characterized by different genomic profiles: CTX-M-15, TEM-1B and SHV-187 genes (ST513); CTX-M-15 and SHV-145 (ST307); SHV-187 and DHA-1 (ST307). Occurrence of ESBL-producing K. pneumoniae in milk filters was 1.2 % (95 % CI 0.4-3.4). All the isolates showed resistance to aminoglycosides, 3rd-generation cephalosporins, and fluoroquinolones. Among the human isolates, two multidrug resistant ESBL-producing K. pneumoniae ST307 were found, thus confirming the circulation of this high-risk lineage between humans and cattle. Our findings suggest that food-producing animals can carry human pathogenic microorganisms harboring resistance genes against carbapenems and 3rd-generation cephalosporins, even if not treated with such antimicrobials. Moreover, on the MDR K. pneumoniae farms, the antimicrobial use was much higher than the Italian median value, thus highlighting the importance of a more prudent use of antibiotics in animal productions.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Shotgun proteomic analysis of ESBL-producing and non-ESBL-producing Klebsiella Pneumoniae clinical isolates
    Enany, Shymaa
    Zakeer, Samira
    Sayed, Ahmed A.
    Magdeldin, Sameh
    [J]. MICROBIOLOGICAL RESEARCH, 2020, 234
  • [2] Resistance to a wide spectrum of antimicrobial agents in ESBL-producing Klebsiella pneumoniae clinical isolates
    Resetarova, S.
    Michalkova-Papajova, D.
    Sodomova, E.
    Gottwaldova, B.
    Rovna, D.
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S469 - S469
  • [3] VIRULENCE CHARACTERISTICS AND GENETIC BACKGROUND OF ESBL-PRODUCING KLEBSIELLA PNEUMONIAE ISOLATES FROM WASTEWATER
    Atmani, Sara Mimi
    Messai, Yamina
    Alouache, Souhila
    Fernandez, Rocio
    Estepa, Vanesa
    Torres, Carmen
    Bakour, Rabah
    [J]. FRESENIUS ENVIRONMENTAL BULLETIN, 2015, 24 (01): : 103 - 112
  • [4] Comparison of Predictors and Mortality Between Bloodstream Infections Caused by ESBL-Producing Escherichia coli and ESBL-Producing Klebsiella pneumoniae
    Scheuerman, Oded
    Schechner, Vered
    Carmeli, Yehuda
    Gutierrez-Gutierrez, Belen
    Calbo, Esther
    Almirante, Benito
    Viale, Pier-Luigy
    Oliver, Antonio
    Ruiz-Garbajosa, Patricia
    Gasch, Oriol
    Gozalo, Monica
    Pitout, Johann
    Akova, Murat
    Pena, Carmen
    Molina, Jose
    Hernandez-Torres, Alicia
    Venditti, Mario
    Prim, Nuria
    Origuen, Julia
    Bou, German
    Tacconelli, Evelina
    Tumbarello, Maria
    Hamprecht, Axel
    Karaiskos, Ilias
    de la Calle, Cristina
    Perez, Federico
    Schwaber, Mitchell J.
    Bermejo, Joaquin
    Lowman, Warren
    Hsueh, Po-Ren
    Navarro-San Francisco, Carolina
    Bonomo, Robert A.
    Paterson, David L.
    Pascual, Alvaro
    Rodriguez-Bano, Jesus
    [J]. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2018, 39 (06): : 660 - 667
  • [5] Antimicrobial resistance and AmpC production in ESBL-producing Klebsiella pneumoniae and Klebsiella quasipneumoniae: A retrospective study in Japanese clinical isolates
    Watanabe, Naoki
    Watari, Tomohisa
    Otsuka, Yoshihito
    Ito, Masahiko
    Yamagata, Kazufumi
    Fujioka, Miyuki
    [J]. PLOS ONE, 2024, 19 (05):
  • [6] Comparison of biofilm formation and efflux pumps in ESBL and carbapenemase producing Klebsiella pneumoniae
    Yazgan, Burak
    Turkel, Ibrahim
    Guckan, Ridvan
    Kilinc, Cetin
    Yildirim, Tuba
    [J]. JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2018, 12 (03): : 156 - 163
  • [7] Colistin resistance in ESBL- and Carbapenemase-producing Escherichia coli and Klebsiella pneumoniae clinical isolates in Cambodia
    Hide, Mallorie
    Meng, Soda
    Cheng, Sokleaph
    Banuls, Anne-Laure
    Santy, Ky
    Chantana, Yai
    Laurent, Denis
    Delvallez, Gauthier
    [J]. JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2024, 38 : 236 - 244
  • [8] Prevalence of the carbapenem-heteroresistant phenotype among ESBL-producing Escherichia coli and Klebsiella pneumoniae clinical isolates
    Tan, Karen
    Nguyen, James
    Nguyen, Kevin
    Huse, Holly K.
    Nieberg, Paul H.
    Wong-Beringer, Annie
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2020, 75 (06) : 1506 - 1512
  • [9] Polyclonal Multidrug ESBL-Producing Klebsiella pneumoniae and Emergence of Susceptible Hypervirulent Klebsiella pneumoniae ST23 Isolates in Mozambique
    Sumbana, Jose Joao
    Santona, Antonella
    Abdelmalek, Nader
    Fiamma, Maura
    Deligios, Massimo
    Manjate, Alice
    Sacarlal, Jahit
    Rubino, Salvatore
    Paglietti, Bianca
    [J]. ANTIBIOTICS-BASEL, 2023, 12 (09):
  • [10] Detection of blaCTX-M genes in ESBL-producing Klebsiella isolates from animals in Croatia
    Pintaric, Selma
    Sttritof, Zrinka
    Perko, Vesna mojcec
    Tumpa, Andrea
    Cvetniic, Marija
    Hadzic, Lana
    [J]. ACTA VETERINARIA HUNGARICA, 2023, 71 (01) : 12 - 15